Healthcare provider profile · identity verified

David Hartig, M.D.

Family Practice · HUNT VALLEY, MD · NPI 1093797995

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	343	108
Atorvastatin Calcium	Atorvastatin Calcium	243	67
Pantoprazole Sodium	Pantoprazole Sodium	195	55
Amlodipine Besylate	Amlodipine Besylate	151	40
Levothyroxine Sodium	Levothyroxine Sodium	126	38
Metoprolol Succinate	Metoprolol Succinate	115	33
Tramadol Hcl	Tramadol Hcl	107	21
Synthroid	Levothyroxine Sodium	102	24
Hydrochlorothiazide	Hydrochlorothiazide	101	31
Gabapentin	Gabapentin	98	32
Xarelto	Rivaroxaban	87	19
Celecoxib	Celecoxib	84	25
Montelukast Sodium	Montelukast Sodium	83	22
Lisinopril	Lisinopril	82	25
Trulicity	Dulaglutide	82	14
Tamsulosin Hcl	Tamsulosin Hcl	76	23
Ozempic	Semaglutide	75	17
Finasteride	Finasteride	74	26
Olmesartan Medoxomil	Olmesartan Medoxomil	71	21
Prednisone	Prednisone	70	31
Alprazolam	Alprazolam	69	22
Famotidine	Famotidine	68	22
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	66	18
Jardiance	Empagliflozin	63	19
Metformin Hcl Er	Metformin Hcl	63	18
Simvastatin	Simvastatin	62	13
Meloxicam	Meloxicam	60	15
Trazodone Hcl	Trazodone Hcl	59	17
Escitalopram Oxalate	Escitalopram Oxalate	58	22
Omeprazole	Omeprazole	58	14
Valsartan	Valsartan	56	15
Eliquis	Apixaban	54	11
Clopidogrel	Clopidogrel Bisulfate	52	14
Nebivolol Hcl	Nebivolol Hcl	49	12
Pravastatin Sodium	Pravastatin Sodium	46	11
Allopurinol	Allopurinol	45	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	45	11
Atenolol	Atenolol	42	14
Ezetimibe	Ezetimibe	42	13
Lorazepam	Lorazepam	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	36	suppressed
Carvedilol	Carvedilol	35	suppressed
Febuxostat	Febuxostat	35	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	34	11
Clonazepam	Clonazepam	34	11
Furosemide	Furosemide	34	suppressed
Losartan Potassium	Losartan Potassium	34	14
Spironolactone	Spironolactone	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Dexlansoprazole Dr	Dexlansoprazole	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Cefuroxime	Cefuroxime Axetil	31	16
Levofloxacin	Levofloxacin	31	23
Baclofen	Baclofen	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Tresiba Flextouch U-100	Insulin Degludec	28	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	26	suppressed
Irbesartan	Irbesartan	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	15
Armodafinil	Armodafinil	23	suppressed
Azithromycin	Azithromycin	23	21
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Methylprednisolone	Methylprednisolone	23	22
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Ramipril	Ramipril	22	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	12
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Metformin Hcl	Metformin Hcl	20	suppressed
Niacin Er	Niacin	20	suppressed
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	11
Lansoprazole	Lansoprazole	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sertraline Hcl	Sertraline Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Fluvastatin Er	Fluvastatin Sodium	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Np Thyroid	Thyroid,pork	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Modafinil	Modafinil	12	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	12	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Desipramine Hcl	Desipramine Hcl	11	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	11	suppressed
Dilantin	Phenytoin Sodium Extended	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error